Skip to content
Home/Companies/Biotech/Rarity Bioscience

Rarity Bioscience

Biotech·Sweden·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Rarity Bioscience?

Rarity Bioscience is currently owned by Navigare Ventures through Navigare Ventures (2021 vintage), since 2022.

Hand-verified · updated 2026-08-17

Navigare Ventures
Investor
Navigare Ventures
Navigare Ventures · 2021 · VC

Key facts

HQSweden
SectorBiotech
StatusActive

More from Navigare Ventures

Other portfolio companies in the same fund.

ScandiEdge
Active
Deep TechSweden· 2026
Basic Genomics
Active
BiotechSweden· 2025
Epigenica
Active
BiotechSweden· 2025
Nordic Forestry Automation
Active
AgTechSweden· 2025
ProteomEdge
Active
BiotechSweden· 2025
Solinide Photonics
Active
Deep TechSweden· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Rarity Bioscience

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Rarity Bioscience?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Rarity Bioscience.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue